| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Consumer health outlet |
| Population | Women |
| Source | Ubie Health (Doctor's Note) |
| URL | ubiehealth.com/doctors-note/testosterone-women-perimenopause-dosage-signs-t-4233e1 (opens in a new tab) |
Specific Claim Evaluated
Low testosterone in women is real and often overlooked, particularly during perimenopause and menopause, and common signs include low libido, persistent fatigue, reduced muscle strength, brain fog and mood changes.
Primary Research Supporting or Contradicting the Claim
Testosterone does not change with natural menopause (Wang et al., 2025). No blood level distinguishes women with and without sexual dysfunction, and data are insufficient for any indication other than hypoactive sexual desire disorder (Davis et al., 2019). A meta-analysis found no cognitive benefit of testosterone in menopause (Faulkner et al., 2026).
Corrected Evidence-Based Interpretation
There is no validated clinical syndrome of testosterone deficiency in women defined by fatigue, muscle weakness, brain fog or mood change. Testosterone is supported only for postmenopausal hypoactive sexual desire disorder after full assessment.
Rationale for Grade
The article attributes common nonspecific symptoms of the menopause transition to low testosterone and links the condition to menopause, which population data do not support. It notes that testosterone is 'only one piece' of hormonal health, but the symptom list invites treatment for indications without evidence. This misinterprets the physiology and the clinical evidence.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect" - Wang Y, Islam RM, Bond M, Davis SR. Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study. EBioMedicine. 2025;121:105972. PMID
Supporting excerpt: "These data do not support menopause per se as an indication for testosterone supplementation."